We are pioneering the use of the mRNAs of the subcutaneous adipose tissue. Our first-mover platform-technology for diagnostics enables highly accurate, cheap and easy test for mass-usage with diseases like MASLD and T2D. We offer hepatologists and diabetologists tools to meet the ever-increasing demands from medical guidelines and treatment recommendations for Dx screening, DDx, CDx, and Px. Future research will expand diagnostics to further diseases, including obesity related cancers, as well as develop novel Tx-concepts for re-establishing functionality to an unhealthy (dysfunctional) adipose tissue.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Erbrichterweg 7a, Bremen,bremen 28357,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- lipozyt-marker.com
- HQ
- Bremen, Bremen
Lipocyte Biomed Gmbh Questions
Lipocyte Biomed Gmbh's website is lipozyt-marker.com
Lipocyte Biomed Gmbh's LinkedIn profile is https://de.linkedin.com/company/lipocyte-biomed
Lipocyte Biomed Gmbh has
5 employees.
View email and phone details for 5
employees at Lipocyte Biomed Gmbh.
Lipocyte Biomed Gmbh's industry is
Biotechnology Research
Lipocyte Biomed Gmbh's top competitors are
Bioecho Life Sciences,
Krankenhaus.de,
Oncoleader,
Zarm,
Mir|detect,
Health Innovation And Ventures Enabler (Hive),
Aphaia Pharma,
Nageb,
Impetus Bioscience,
Fs Life Science Investment Gmbh.
Lipocyte Biomed Gmbh's categories are Biotechnology Research
Lipocyte Biomed Gmbh's founding year is 2014
